The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia.

about

The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia.

Item

http://www.wikidata.org/entity/Q47809709

description

2017 nî lūn-bûn

@nan

2017 թվականի հոկտեմբերին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

name

The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia.

@en

The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia.

@nl

type

Item

label

The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia.

@en

The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia.

@nl

prefLabel

The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia.

@en

The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia.

@nl

P1476

The ABCs of Immunotherapy for Adult Patients With B-Cell Acute Lymphoblastic Leukemia.

@en

P2093

Adebayo Ogunniyi

http://www.w3.org/2001/XMLSchema#string

Amanda N Seddon

http://www.w3.org/2001/XMLSchema#string

Amber C King

http://www.w3.org/2001/XMLSchema#string

Larry W Buie

http://www.w3.org/2001/XMLSchema#string

Ryan J Daley

http://www.w3.org/2001/XMLSchema#string

Troy Z Horvat

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity and management in CAR T-cell therapy

Binding of submaximal C1q promotes complement-dependent cytotoxicity (CDC) of B cells opsonized with anti-CD20 mAbs ofatumumab (OFA) or rituximab (RTX): considerably higher levels of CDC are induced by OFA than by RTX.

Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia.

Current concepts in the diagnosis and management of cytokine release syndrome.

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

Chemoimmunotherapy with a modified hyper-CVAD and rituximab regimen improves outcome in de novo Philadelphia chromosome-negative precursor B-lineage acute lymphoblastic leukemia.

Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia.

Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies.

Toxicity management for patients receiving novel T-cell engaging therapies.

The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20.

P304

268-276

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028017736539

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29025266

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

leukemia